Wegovy OK'd for Teens With Obesity

(MedPage Today) -- The FDA approved injectable semaglutide 2.4 mg (Wegovy) for people with obesity ages 12 and up, maker Novo Nordisk announced. When paired with diet and exercise, it's now indicated for use in adolescents with an initial BMI...
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news